In-111 DTPA and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose
Determining the interaction of In-111 DTPA and Kisqali Femara Co-Pack 600 mg-2.5 mg Dose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111
Generic Name: letrozole / ribociclib
Brand name: Kisqali Femara Co-Pack 200 mg-25 mg Dose, Kisqali Femara Co-Pack 400 mg-25 mg Dose, Kisqali Femara Co-Pack 600 mg-25 mg Dose
Synonyms: Kisqali Femara Co-Pack 200 mg-2.5 mg Dose, Kisqali Femara Co-Pack
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- In-111 DTPA-Kitabis Pak
- In-111 DTPA-Kitabis Pak inhalation
- In-111 DTPA-Klofensaid II
- In-111 DTPA-Klonopin
- In-111 DTPA-Klonopin Wafer
- In-111 DTPA-Klonopin Wafers
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Inamrinone
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Inapsine
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Inatal Advance
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Inatal Ultra
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Inbrija
- Kisqali Femara Co-Pack 600 mg-2.5 mg Dose-Incassia